NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
The effects of autogenic-feedback training on motion sickness severity and heart rate variability in astronautsSpace motion sickness (SMS) affects 50 percent of all people during early days of spaceflight. This study describes the results of two Shuttle flight experiments in which autogenic-feedback training (AFT), a physiological conditioning method, was tested as a treatment for this disorder. Of the six who were designated as flight subjects (two women and four men), three were given treatment and three served as controls (i.e., no AFT). Treatment subjects were given 6 hours of preflight AFT. Preflight results showed that AFT produced a significant increase in tolerance to rotating chair motion sickness tests. Further, this increased tolerance was associated with changes in specific physiological responses and reports of reduced malaise. Flight results showed that two of the three control subjects experienced repeated vomiting on the first mission day, while one subject experienced only moderate malaise. Of the three treatment subjects, one experienced mild discomfort, one moderate discomfort, and one severe motion sickness. Only the three control subjects took medication for symptom suppression. Measures of cardiac function reflective of vagal control were shown to be affected especially strongly on the first day of space flight. AFT given for control of heart rate, respiration, and other autonomic activity influenced both the vagal control measures and SMS. These data suggest that AFT may be an effective treatment for space motion sickness; however, this cannot be demonstrated conclusively with the small number of subjects described.
Document ID
19950007248
Acquisition Source
Legacy CDMS
Document Type
Technical Memorandum (TM)
Authors
Toscano, William B.
(California Univ. Los Angeles, CA., United States)
Cowings, Patricia S.
(NASA Ames Research Center Moffett Field, CA, United States)
Date Acquired
September 6, 2013
Publication Date
October 1, 1994
Subject Category
Aerospace Medicine
Report/Patent Number
NAS 1.15:108840
NASA-TM-108840
A-94116
Accession Number
95N13661
Funding Number(s)
PROJECT: RTOP 199-70-12-14
CONTRACT_GRANT: NCC2-115
Distribution Limits
Public
Copyright
Work of the US Gov. Public Use Permitted.
No Preview Available